BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

M Xing, R Liu, X Liu, AK Murugan, G Zhu… - Journal of clinical …, 2014 - ascopubs.org
Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …

BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

M Xing, R Liu, X Liu, AK Murugan, G Zhu… - Journal of Clinical …, 2014 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> To investigate the prognostic value
of the BRAF V600E mutation and the recently identified TERT promoter mutation chr5 …

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

M Xing, R Liu, X Liu, AK Murugan… - Journal of Clinical …, 2014 - pure.johnshopkins.edu
Purpose: To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …

[PDF][PDF] BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

M Xing, R Liu, X Liu, AK Murugan, G Zhu, MA Zeiger… - J Clin …, 2014 - researchgate.net
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive
Papillary Thyroid Cancer With Highest Recurren Page 1 BRAF V600E and TERT Promoter …

[HTML][HTML] BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

M Xing, R Liu, X Liu, AK Murugan, G Zhu… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive
Papillary Thyroid Cancer With Highest Recurrence - PMC Back to Top Skip to main content NIH …

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

M Xing, R Liu, X Liu, AK Murugan, G Zhu… - Journal of Clinical …, 2014 - europepmc.org
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary
thyroid cancer with highest recurrence. - Abstract - Europe PMC Sign in | Create an account …

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

M Xing, R Liu, X Liu, AK Murugan… - Journal of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

M Xing, R Liu, X Liu… - Journal of …, 2014 - utsouthwestern.elsevierpure.com
Purpose: To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

M Xing, R Liu, X Liu, AK Murugan, G Zhu… - Journal of Clinical …, 2014 - europepmc.org
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary
thyroid cancer with highest recurrence. - Abstract - Europe PMC Sign in | Create an account …